Dysregulation of pulsatility in aging. IV. Pulsatile signaling and cardiovascular aging: Functions and regulation of natriuretic peptide signaling

Ageing Research Reviews

Volumn 7, Issue 3, 2008, Pages 151-163

  Charloux, Anne ^a   Brandenberger, Gabrielle ^a   Piquard, François ^a   Geny, Bernard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Aging; Atrial natriuretic peptide; Brain natriuretic peptide; Pulsatile secretion; Renal efficiency; Ultradian rhythm

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

FLUID BALANCE; GERIATRIC CARE; HEART FUNCTION; HORMONE BLOOD LEVEL; HUMAN; PATHOPHYSIOLOGY; PROTEIN SECRETION; SHORT SURVEY; ULTRADIAN RHYTHM;

AGING; ATRIAL NATRIURETIC FACTOR; HUMANS; KIDNEY; NATRIURETIC PEPTIDE, BRAIN;

EID: 51849167052     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2007.12.001     Document Type: Short Survey

References (80)

1. Ahluwalia A., MacAllister R.J., and Hobbs A.J. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res. Cardiol. 99 (2004) 83-89
2. Belchetz P.E., Plant T.M., Nakai Y., Keogh E.J., and Knobil E. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 202 (1978) 631-633
3. Bentzen H., Pedersen R.S., Pedersen H.B., Nyvad O., and Pedersen E.B. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure. Clin. Sci. (Lond.) 104 (2003) 303-312
4. Brandenberger G., Ehrhart J., Piquard F., and Simon C. Inverse coupling between ultradian oscillations in delta wave activity and heart rate variability during sleep. Clin. Neurophysiol. 112 (2001) 992-996
5. Brandenberger G., Follenius M., Goichot B., Saini J., Spiegel K., Ehrhart J., et al. Twenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycle. J. Hypertens. 12 (1994) 277-283
6. Brenner B.M., Ballermann B.J., Gunning M.E., and Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70 (1990) 665-699
7. Burnett Jr. J.C. Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases: what's on the horizon. J. Cardiol. 48 (2006) 235-241
8. Charloux A., Chaouat A., Brandenberger G., Piquard F., Weitzenblum E., and Geny B. Reduced pulsatility does not explain renal hyporesponsiveness to cardiac natriuretic peptides in pulmonary hypertension. Peptides 27 (2006) 864-870
9. Charloux A., Chaouat A., Piquard F., Brandenberger G., Weitzenblum E., and Geny B. Renal hyporesponsiveness to brain natriuretic peptide: both generation and renal activity of cGMP are decreased in patients with pulmonary hypertension. Peptides 27 (2006) 2993-2999
10. Charloux A., Gronfier C., Lonsdorfer-Wolf E., Piquard F., and Brandenberger G. Aldosterone release during the sleep-wake cycle in humans. Am. J. Physiol. 276 (1999) E43-E49
11. Charloux A., Piquard F., Doutreleau S., Brandenberger G., and Geny B. Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur. J. Clin. Invest. 33 (2003) 769-778
12. Charloux A., Piquard F., Ehrhart J., Mettauer B., Geny B., Simon C., et al. Time-courses in renin and blood pressure during sleep in humans. J. Sleep Res. 11 (2002) 73-79
13. Charloux A., Piquard F., Geny B., Ehrhart J., and Brandenberger G. Circulating endothelin parallels arterial blood pressure during sleep in healthy subjects. Regul. Pept. 119 (2004) 133-138
14. Cho K.W., Seul K.H., Kim S.H., Seul K.M., and Koh G.Y. Atrial pressure, distension, and pacing frequency in ANP secretion in isolated perfused rabbit atria. Am. J. Physiol. 260 (1991) R39-R46
15. Clark B.A., Elahi D., Shannon R.P., Wei J.Y., and Epstein F.H. Influence of age and dose on the end-organ responses to atrial natriuretic peptide in humans. Am. J. Hypertens. 4 (1991) 500-507
16. Clerico A., Recchia F.A., Passino C., and Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H17-H29
17. Conte G., Bellizzi V., Cianciaruso B., Minutolo R., Fuiano G., and De Nicola L. Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease. Kidney Int. Suppl. 59 (1997) S28-S32
18. Cugini P., Lucia P., Di Palma L., Re M., Canova R., Gasbarrone L., et al. The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects. Clin. Auton. Res. 2 (1992) 113-118
19. Davis K.M., Fish L.C., Minaker K.L., and Elahi D. Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from disease. J. Gerontol. A Biol. Sci. Med. Sci. 51 (1996) M95-M101
20. de Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981) 89-94
21. de Bold A.J., Bruneau B.G., and Kuroski de Bold M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc. Res. 31 (1996) 7-18
22. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
23. DePriest D., Zimmermann C., and Baylis C. Renal effects of administered atrial natriuretic peptide in the conscious, aging rat. Life Sci. 46 (1990) 785-792
24. Duggan J., Kilfeather S., Lightman S.L., O'Brien E., and O'Malley K. Plasma atrial natriuretic peptide concentration and platelet atrial natriuretic peptide binding site density in ageing and hypertension. Clin. Sci. (Lond.) 81 (1991) 509-514
25. El-Armouche A., Zolk O., Rau T., and Eschenhagen T. Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc. Res. 60 (2003) 478-487
26. Epstein M. Aging and the kidney. J. Am. Soc. Nephrol. 7 (1996) 1106-1122
27. Ezaki H., Matsushita S., Shiraki M., Kuramoto K., and Yamaji T. Clinical evaluation of the plasma levels of immunoreactive atrial natriuretic peptide in elderly patients with heart diseases. J. Am. Geriatr. Soc. 36 (1988) 537-541
28. Ferder L.F., Inserra F., and Basso N. Advances in our understanding of aging: role of the rennin-angiotensin system. Curr. Opin. Pharmacol. 2 (2002) 189-194
29. Follenius M., Brandenberger G., and Saini J. Lack of diurnal rhythm in plasma atrial natriuretic peptide. Life Sci. 51 (1992) 143-149
30. Geny B., Piquard F., Follenius M., Mettauer B., Schaefer A., Canguilhem B., et al. Role of cardiac innervation in atrial natriuretic peptide secretion in transplanted heart recipients. Am. J. Physiol. 265 (1993) F112-F118
31. Geny B., Richard R., Mettauer B., Lonsdorfer J., and Piquard F. Cardiac natriuretic peptides during exercise and training after heart transplantation. Cardiovasc. Res. 51 (2001) 521-528
32. Giannessi D., Andreassi M.G., Del Ry S., Clerico A., Colombo M.G., and Dini N. Possibility of age regulation of the natriuretic peptide C-receptor in human platelets. J. Endocrinol. Invest. 24 (2001) 8-16
33. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin. Chem. 50 (2004) 1503-1510
34. Goldbeter A. Computational approaches to cellular rhythms. Nature 420 (2002) 238-245
35. Grantham J.A., and Burnett J.C.J. Natriuretic peptides in cardiovascular disease: a focus on congestive heart failure. In: Samson W.K., and Levin E.R. (Eds). Natriuretic peptides in health and disease (1997), Humana Press, Totowa, New Jersey
36. Heim J.M., Gottmann K., Weil J., Strom T.M., and Gerzer R. Effects of a bolus dose of atrial natriuretic factor in young and elderly volunteers. Eur. J. Clin. Invest. 19 (1989) 265-271
37. Iida H., and Shibata Y. Phasic secretion of newly synthesized atrial natriuretic factor from unstimulated atrial myocytes in culture. Circ. Res. 74 (1994) 659-668
38. Jamieson J.D., and Palade G.E. Specific granules in atrial muscle cells. J. Cell Biol. 23 (1964) 151-172
39. Jansen T.L., Smits P., Tan A.C., and Thien T. Attenuated forearm vasodilator response to atrial natriuretic factor in the elderly. Hypertension 18 (1991) 640-647
40. Jansen T.L., Tan A.C., Smits P., de Boo T., Benraad T.J., and Thien T. Hemodynamic effects of atrial natriuretic factor in young and elderly subjects. Clin. Pharmacol. Ther. 48 (1990) 179-188
41. Jensen K.T., Carstens J., Ivarsen P., and Pedersen E.B. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand. J. Clin. Lab. Invest. 57 (1997) 529-540
42. Kato J., Kitamura K., Uemura T., Kuwasako K., Kita T., Kangawa K., et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens. Res. 25 (2002) 887-892
43. Kawai K., Hata K., Tanaka K., Kubota Y., Inoue R., Masuda E., et al. Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging. Am. J. Cardiol. 93 (2004) 719-723
44. Kisch B. Electron microscopy of the atrium of the heart. I. Guinea pig. Exp. Med. Surg. 14 (1956) 99-112
45. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res. Cardiol. 99 (2004) 76-82
46. Kuroski-de Bold M.L., and de Bold A.J. Stretch-secretion coupling in atrial cardiocytes. Dissociation between atrial natriuretic factor release and mechanical activity. Hypertension 18 (1991) III169-III178
47. Lai P., Nazian S.J., Gower Jr. W.R., Landon C.S., and Dietz J.R. Increased bioactivity of rat atrial extracts: relation to aging and blood pressure regulation. J. Gerontol. A. Biol. Sci. Med. Sci. 55 (2000) B390-B395
48. Lavie P., Luboshitzky R., Kleinhouse N., Shen-Orr Z., Barzilai D., Glick S.M., et al. Rhythms in urine flow are not correlated with rhythmic secretion of antidiuretic hormone (ADH) in well hydrated men. Horm. Metab. Res. 12 (1980) 66-70
49. Lee C.Y., and Burnett Jr. J.C. Natriuretic peptides and therapeutic applications. Heart Fail Rev. 12 (2007) 131-142
50. Lennox S.D., Mulkerrin E., Penney M., and Woodhouse K. Plasma atrial natriuretic polypeptide in the elderly: age or hypertension?. Arch. Gerontol. Geriatr. 19 (1994) 1-5
51. Leosco D., Ferrara N., Landino P., Romano G., Sederino S., Cacciatore F., et al. Effects of age on the role of atrial natriuretic factor in renal adaptation to physiologic variations of dietary salt intake. J. Am. Soc. Nephrol. 7 (1996) 1045-1051
52. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N. Engl. J. Med. 339 (1998) 321-328
53. Luchner A., Burnett Jr. J.C., Jougasaki M., Hense H.W., Heid I.M., Muders F., et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J. Hypertens. 18 (2000) 1121-1128
54. McDowell G., Cave M., Bainbridge A., Danton M., Shaw C., Buchanan K.D., et al. Is the secretion of atrial natriuretic peptide in man under neural control?. Eur. Heart J. 21 (2000) 498-503
55. Morrow L.A., Morganroth G.S., Hill T.J., Sanfield J.A., Rosen S.G., Grekin R.J., et al. Atrial natriuretic factor in the elderly: diminished response to epinephrine. Am. J. Physiol. 257 (1989) E866-E870
56. Mulkerrin E.C., Brain A., Hampton D., Penney M.D., Sykes D.A., Williams J.D., et al. Reduced renal hemodynamic response to atrial natriuretic peptide in elderly volunteers. Am. J. Kidney Dis. 22 (1993) 538-544
57. Nageh T., Chin D., Cooke J.C., Meehan N., Monaghan M.J., and Sherwood R.A. Interpretation of plasma brain natriuretic peptide concentrations may require adjustment for patient's age. Ann. Clin. Biochem. 39 (2002) 151-153
58. Nielsen C.B., Bech J.N., and Pedersen E.B. Epoprostenol increases plasma level of atrial natriuretic peptide in humans. Clin. Sci. (Lond.) 90 (1996) 87-89
59. Nomura H., Hayashi T., Esaki T., Kanda S., Kano H., Hattori A., et al. Standardization of plasma brain natriuretic peptide concentrations in older Japanese-relationship to latent renal dysfunction and ischemic heart disease. J. Am. Geriatr. Soc. 50 (2002) 1504-1509
60. Nugent A.M., Onuoha G.N., McEneaney D.J., Steele I.C., Hunter S.J., Prasanna K., et al. Variable patterns of atrial natriuretic peptide secretion in man. Eur. J. Clin. Invest. 24 (1994) 267-274
61. Ogawa T., Linz W., Stevenson M., Bruneau B.G., Kuroski de Bold M.L., Chen J.H., et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 93 (1996) 2059-2067
62. Ohashi M., Fujio N., Nawata H., Kato K., Ibayashi H., Kangawa K., et al. High plasma concentrations of human atrial natriuretic polypeptide in aged men. J. Clin. Endocrinol. Metab. 64 (1987) 81-85
63. Or K., Richards A.M., Espiner E.A., Yandle T., Gilchrist N., and Sainsbury R. Effect of low dose infusions of ile-atrial natriuretic peptide in healthy elderly males: evidence for a postreceptor defect. J. Clin. Endocrinol. Metab. 76 (1993) 1271-1274
64. Pedersen E.B., Bacevicius E., Bech J.N., Solling K., and Pedersen H.B. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure. Clin. Sci. (Lond.) 110 (2006) 491-501
65. Pedersen E.B., Pedersen H.B., and Jensen K.T. Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans. Clin. Sci. (Lond.) 97 (1999) 201-206
66. Piquard F., Richard R., Charloux A., Doutreleau S., Hannedouche T., Brandenberger G., et al. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients. J. Appl. Physiol. 93 (2002) 569-575
67. Pollack J.A., Skvorak J.P., Nazian S.J., Landon C.S., and Dietz J.R. Alterations in atrial natriuretic peptide (ANP) secretion and renal effects in aging. J. Gerontol. A Biol. Sci. Med. Sci. 52 (1997) B196-B202
68. Portaluppi F., Bagni B., degli Uberti E., Montanari L., Cavallini R., Trasforini G., et al. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J. Hypertens. 8 (1990) 85-95
69. Portaluppi F., Vergnani L., and degli Uberti E.C. Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach. Chronobiol. Int. 10 (1993) 176-189
70. Rademaker M.T., and Richards A.M. Cardiac natriuretic peptides for cardiac health. Clin. Sci. (Lond.) 108 (2005) 23-36
71. Ramos H., and de Bold A.J. Gene expression, processing, and secretion of natriuretic peptides: physiologic and diagnostic implications. Heart Fail. Clin. 2 (2006) 255-268
72. Reckelhoff J.F., and Baylis C. Proximal tubular metalloprotease activity is decreased in the senescent rat kidney. Life Sci. 50 (1992) 959-963
73. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol. 40 (2002) 976-982
74. Ruskoaho H., Leskinen H., Magga J., Taskinen P., Mantymaa P., Vuolteenaho O., et al. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J. Mol. Med. 75 (1997) 876-885
75. Sayama H., Nakamura Y., Saito N., and Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?. Coron Artery Dis. 10 (1999) 537-540
76. Sayama H., Nakamura Y., Saito N., Kinoshita M., and Suda M. Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 46 (2000) 71-77
77. Tan A.C., Hoefnagels W.H., Swinkels L.M., Kloppenborg P.W., and Benraad T.J. The effect of volume expansion on atrial natriuretic peptide and cyclic guanosine monophosphate levels in young and aged subjects. J. Am. Geriatr. Soc. 38 (1990) 1215-1219
78. Tan A.C., Jansen T.L., Termond E.F., Russel F.G., Thien T., Kloppenborg P.W., et al. Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur. J. Clin. Pharmacol. 42 (1992) 449-452
79. Tan A.C., Jansen T.L., Thien T., Kloppenborg P.W., and Benraad T.J. Comparison of cyclic guanosine monophosphate response to infusion of atrial natriuretic peptide in young and elderly subjects. J. Am. Geriatr. Soc. 41 (1993) 1241-1244
80. Veldhuis J.D. A parsimonious model of amplitude and frequency modulation of episodic hormone secretory bursts as a mechanism for ultradian signalling by endocrine glands. In: Llyod D., and Rossi E.L. (Eds). Ultradian Rhythms in Life Processes (1992), Springer-Verlag, London